| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
Blood brain barrierCNS (Metabolism of injured CNS)Ultrasound (Toxicity and therapeutic use)Drug deliveryNervous system (Neurodegeneration)Blood vessels (Physiology)Blodd vessels (Permeability)Tight junctionClaudin5Antibiotics (BASKET)| 1 | 2009 | The blood-brain barrier in neurodegenerative disease: a rhetorical perspective. | 
| + | - | nl | J Neurochem 111(2):291-314 (2009) |
| 2 | 1998 | CNS drug design based on principles of blood-brain barrier transport. | 
| + | - | nl | J Neurochem 70(5):1781-92 (1998) |
| 3 | 2010 | Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage. | 
| + | - | nl | J Cereb Blood Flow Metab 30(4):689-702 (2010) |
| 4 | 1988 | Mediators of blood-brain barrier dysfunction and formation of vasogenic brain edema. | 
| + | - | nl | J Cereb Blood Flow Metab 8(5):621-34 (1988) |
| 5 | 2009 | Mechanisms of the penetration of blood-borne substances into the brain. | 
| + | - | nl | Curr Neuropharmacol 7(2):142-9 (2009) |
| 6 | 2008 | Intranasal administration of acetylcholinesterase inhibitors. | 
| + | - | nl | BMC Neurosci 9 Suppl 3(-):S6 (2008) |
| 7 | 2008 | Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. | 
| + | - | nl | BMC Neurosci 9 Suppl 3(-):S5 (2008) |
| 8 | 2008 | Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS. | 
| + | - | nl | BMC Neurosci 9 Suppl 3(-):S4 (2008) |
| 9 | 2008 | Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease. | 
| + | - | nl | BMC Neurosci 9 Suppl 3(-):S2 (2008) |
| 10 | 2009 | Characteristics of compounds that cross the blood-brain barrier. | 
| + | - | nl | BMC Neurol 9 Suppl 1(-):S3 (2009) |
| 11 | 2006 | Trojan horse or proton force: finding the right partner(s) for toxin translocation. | 
| + | - | nl | Neurotox Res 9(2-3):63-71 (2006) |
| 12 | 2005 | The blood-brain barrier/neurovascular unit in health and disease. | 
| + | - | nl | Pharmacol Rev 57(2):173-85 (2005) |
| 13 | 1997 | The blood-brain barrier in neuroinflammatory diseases. | 
| + | - | nl | Pharmacol Rev 49(2):143-55 (1997) |
| 14 | 2004 | New aspects of the blood-brain barrier transporters; its physiological roles in the central nervous system. | 
| + | - | nl | Biol Pharm Bull 27(10):1489-96 (2004) |
| 15 | 2008 | Postulated role of vasoactive neuropeptide-related immunopathology of the blood brain barrier and Virchow-Robin spaces in the aetiology of neurological-related conditions. | 
| + | - | nl | Mediators Inflamm 2008(-):792428 (2008) |
| 16 | 2009 | The gut immune barrier and the blood-brain barrier: are they so different? | 
| + | - | nl | Immunity 31(5):722-35 (2009) |
| 17 | 2004 | Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. | 
| + | - | nl | J Leukoc Biol 75(3):388-97 (2004) |
| 18 | 2000 | Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia. | 
| + | - | nl | J Leukoc Biol 68(3):413-22 (2000) |
| 19 | 2007 | The blood-brain barrier and cancer: transporters, treatment, and Trojan horses. | 
| + | - | nl | Clin Cancer Res 13(6):1663-74 (2007) |
| 20 | 2006 | The dam breaks: disruption of the blood-brain barrier in diabetes mellitus. | 
| + | - | nl | Am J Physiol Heart Circ Physiol 291(6):H2595-6 (2006) |
| 21 | 1985 | The blood-brain barrier. Transport across the cerebral endothelium. | 
| + | - | nl | Circ Res 57(2):213-22 (1985) |
| 22 | 2000 | The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery. | 
| + | - | nl | Neuro Oncol 2(1):45-59 (2000) |
| 23 | 2005 | Blood-brain barrier genomics, proteomics, and new transporter discovery. | 
| + | - | nl | NeuroRx 2(1):151-61 (2005) |
| 24 | 2005 | Drug transport to brain with targeted liposomes. | 
| + | - | nl | NeuroRx 2(1):99-107 (2005) |
| 25 | 2005 | Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. | 
| + | - | nl | NeuroRx 2(1):86-98 (2005) |
| 26 | 2005 | Active efflux across the blood-brain barrier: role of the solute carrier family. | 
| + | - | nl | NeuroRx 2(1):73-85 (2005) |
| 27 | 2005 | Brain-to-blood transporters for endogenous substrates and xenobiotics at the blood-brain barrier: an overview of biology and methodology. | 
| + | - | nl | NeuroRx 2(1):63-72 (2005) Terasaki T |
| 28 | 2005 | Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems. | 
| + | - | nl | NeuroRx 2(1):54-62 (2005) |
| 29 | 2005 | Development of neuropeptide drugs that cross the blood-brain barrier. | 
| + | - | nl | NeuroRx 2(1):44-53 (2005) |
| 30 | 2005 | Localization of brain endothelial luminal and abluminal transporters with immunogold electron microscopy. | 
| + | - | nl | NeuroRx 2(1):27-43 (2005) |
| 31 | 2005 | How to measure drug transport across the blood-brain barrier. | 
| + | - | nl | NeuroRx 2(1):15-26 (2005) |
| 32 | 2004 | Cell therapy in Huntington's disease. | 
| + | - | nl | NeuroRx 1(4):394-405 (2004) |
| 33 | 2010 | Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. | 
| + | - | nl | Radiology 255(2):415-25 (2010) |
| 34 | 2006 | Imaging and nanomedicine for diagnosis and therapy in the central nervous system: report of the eleventh annual Blood-Brain Barrier Disruption Consortium meeting. | 
| + | - | nl | AJNR Am J Neuroradiol 27(3):715-21 (2006) |
| 35 | 2002 | Advances in the understanding of the blood-brain barrier in neuro-oncology. | 
| + | - | nl | AJNR Am J Neuroradiol 23(10):1807-10 (2002) |
| 36 | 2006 | CNS drug delivery: opioid peptides and the blood-brain barrier. | 
| + | - | nl | AAPS J 8(1):E76-88 (2006) |
| 37 | 2008 | Recent advances in blood-brain barrier disruption as a CNS delivery strategy. | 
| + | - | nl | AAPS J 10(1):166-77 (2008) |
| 38 | 2002 | Peptide delivery to the brain via adsorptive-mediated endocytosis: advances with SynB vectors. | 
| + | - | nl | AAPS PharmSci 4(4):E26 (2002) |
| 39 | 2008 | Ultrasound for drug and gene delivery to the brain. | 
| + | - | nl | Adv Drug Deliv Rev 60(10):1209-17 (2008) |
| 40 | 2011 | In vitro models of the blood-brain barrier. | 
| + | - | nl | Acta Neurobiol Exp (Wars) 71(1):113-28 (2011) |
| 41 | 2007 | Neuron-glial interactions in blood-brain barrier formation. | 
| + | - | nl | Annu Rev Neurosci 30(-):235-58 (2007) |
| 42 | 2010 | Mouse models of neurological disorders: a view from the blood-brain barrier. | 
| + | - | nl | Biochim Biophys Acta 1802(10):881-8 (2010) |
| 43 | 2009 | Pericyte signaling in the neurovascular unit. | 
| + | - | nl | Stroke 40(3 Suppl):S13-5 (2009) |
| 44 | 2003 | Holey barrier: claudins and the regulation of brain endothelial permeability. | 
| + | - | nl | J Cell Biol 161(3):459-60 (2003) |
| 45 | 2010 | Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. | 
| + | - | nl | Clin Microbiol Rev 23(4):858-83 (2010) |
| 46 | 2008 | Physiology and pharmacological role of the blood-brain barrier. | 
| + | - | nl | Pharmacol Rep 60(5):600-22 (2008) |
| 47 | 2002 | Astrocyte-endothelial interactions and blood-brain barrier permeability. | 
| + | - | nl | J Anat 200(6):629-38 (2002) |
| 48 | 2002 | Blood-brain barrier breakdown in septic encephalopathy and brain tumours. | 
| + | - | nl | J Anat 200(6):639-46 (2002) |